< Back to previous page
Publication
CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress
Journal Contribution - Journal Article Conference Contribution
Journal: ANNALS OF ONCOLOGY
ISSN: 0923-7534
Volume: 29
Pages: 84 - 84
Publication year:2018